Treatment of Keratosis Pilaris With 810 nm Diode Laser (KP)
The investigators hope to establish whether or not the diode laser, a longer-wavelength laser, is effective in treating keratosis pilaris, and hopefully opening a door into the discussion and management of this skin condition. The primary outcome of interest is the difference in the overall blind rater severity scores of the treated versus the untreated sites. The secondary outcome of interest is the change in the patient's self-rated severity score of the treated site. To account for potential natural disease progression or regression, the investigators will also compare patient mean changes to the mean changes in severity scores of the untreated site.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||Treatment of Keratosis Pilaris With 810 nm Diode Laser|
- Difference in severity scores [ Time Frame: 4 wks ] [ Designated as safety issue: No ]Difference in the overall blind rater severity scores of the treated versus the untreated sites
- Patient self-rated severity [ Time Frame: 4 wks ] [ Designated as safety issue: No ]Change in the patient's self-rated severity score of the treated site.
|Study Start Date:||March 2011|
|Study Completion Date:||October 2011|
|Primary Completion Date:||October 2011 (Final data collection date for primary outcome measure)|
|No Intervention: No Laser Treatment|
Active Comparator: 45-60 J Diode Laser Therapy
Diode laser therapy will be initiated at 45-60 J for 30 ms to 100 ms.
Device: Diode Laser
810 nm diode laser
Please refer to this study by its ClinicalTrials.gov identifier: NCT01281644
|United States, Illinois|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Murad Alam, MD||Northwestern University|